Cargando…

The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain

POCKETT R.D., CASTELLANO D., MCEWAN P., OGLESBY A., BARBER B.L. & CHUNG K. (2010) European Journal of Cancer Care19, 755–760 The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain Metasta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pockett, RD, Castellano, D, McEwan, P, Oglesby, A, Barber, BL, Chung, K
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035821/ https://www.ncbi.nlm.nih.gov/pubmed/19708928 http://dx.doi.org/10.1111/j.1365-2354.2009.01135.x

Ejemplares similares

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
por: Lobo-Martins, Soraia, et al.
Publicado: (2020)

Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer
por: Hammond, Emmanuel Nii Boye, et al.
Publicado: (2021)

Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study
por: Pockett, Rhys D., et al.
Publicado: (2015)

Exploiting machine learning for predicting skeletal-related events in cancer patients with bone metastases
por: Wang, Zhiyu, et al.
Publicado: (2016)

Observations on Prostatic Cancer with Metastases in Bone
por: Charteris, Alexander A.
Publicado: (1927)

Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
por: von Moos, Roger, et al.
Publicado: (2015)

Health state utilities for skeletal-related events secondary to bone metastases
por: Matza, Louis S., et al.
Publicado: (2013)

Prostate Cancer and Bone Metastases: The Underlying Mechanisms
por: Wong, Sok Kuan, et al.
Publicado: (2019)

Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.
por: Autzen, P., et al.
Publicado: (1998)

The Economic Burden of Metastatic Castration Resistant Prostate Cancer and Skeletal Related Events in Japanese University Hospitals
por: Satoh, Takefumi, et al.
Publicado: (2018)

Bone metastases and skeletal-related events from neuroendocrine tumors
por: Van Loon, Katherine, et al.
Publicado: (2015)

Paradoxical response of prostate cancer skeletal metastases to androgen deprivation therapy
por: Wosnitzer, Brian, et al.
Publicado: (2015)

Risk Factors, Patterns, and Distribution of Bone Metastases and Skeletal-Related Events in High-Risk Breast Cancer Patients
por: Anwar, Sumadi Lukman, et al.
Publicado: (2022)

Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer
por: Hess, Gregory, et al.
Publicado: (2012)

Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Burden of disease due to cancer in Spain
por: Fernández de Larrea-Baz, Nerea, et al.
Publicado: (2009)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases
por: Liepe, K, et al.
Publicado: (2003)

Surgery of skeletal metastases in 306 patients with prostate cancer: Indications, complications, and survival
por: Weiss, Rüdiger J, et al.
Publicado: (2012)

Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark
por: Jensen, Annette Ø, et al.
Publicado: (2011)

Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain
por: Ferrer Albiach, Carlos, et al.
Publicado: (2019)

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
por: Smith, M. R., et al.
Publicado: (2015)

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
Publicado: (2015)

Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
por: Müller, Arndt-Christian, et al.
Publicado: (2022)

Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients
por: Roato, Ilaria, et al.
Publicado: (2008)

Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller, Channing J, et al.
Publicado: (2012)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Current perspectives on bone metastases in castrate-resistant prostate cancer
por: Logothetis, Christopher, et al.
Publicado: (2018)

Tumor- and Osteoblast-Derived Periostin in Prostate Cancer bone Metastases
por: Sun, Chuan-Yu, et al.
Publicado: (2022)

Prostate cancer bone metastases biology and clinical management (Review)
por: Archer Goode, Emily, et al.
Publicado: (2023)

Distinguishable Colorimetric Biosensor for Diagnosis of Prostate Cancer Bone Metastases
por: Li, Ming, et al.
Publicado: (2023)

Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer
por: Amoako, Yaw Ampem, et al.
Publicado: (2019)

Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009
por: Meier, Geneviève C., et al.
Publicado: (2020)

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
por: de la Piedra, C, et al.
Publicado: (2013)

Markers of bone turnover for the management of patients with bone metastases from prostate cancer
por: Garnero, P, et al.
Publicado: (2000)

Influence of alcohol sensitivity on bone metastases and skeletal-related events in primary operable breast cancer: A retrospective cohort study
por: Tanda, Naoko, et al.
Publicado: (2022)

Distribution Features of Skeletal Metastases: A Comparative Study between Pulmonary and Prostate Cancers
por: Wang, Changyin, et al.
Publicado: (2015)

Skeletal-Related Events After Surgery With or Without Radiotherapy for Bone Metastases to Weight-Bearing Bones
por: Lanier, Claire M, et al.
Publicado: (2022)

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer
por: Hagiwara, May, et al.
Publicado: (2013)

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
por: Dorff, Tanya B, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_amar8u3t2veo2n8vrqv6siqo9u